PGY1 Pharmacy Portland, Oregon

Caring for our communities for 75 years, Kaiser Permanente Northwest serves over 620,000 members in the Portland metro area, from Eugene, Oregon to Longview, Washington. Approximately 1020 pharmacy employees provide services in 26 pharmacy locations and 2 hospitals.

Purpose: PGY1 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training.

It is a 12 month, multi-site program in the Portland-metro area. The Kaiser Permanente Northwest PGY1 Residency has an ambulatory care focus and cultivates the development of leadership and clinical skills to allow residents to provide evidence-based and patient-focused care, setting them up for a career that serves to advance pharmacy practice.

---

Pharmacy Services

KPNW pharmacists work collaboratively with healthcare practitioners across the care continuum including inpatient, outpatient, transitions of care, home infusion, oncology, ambulatory care, academia, and administrative settings. With outpatient pharmacy services in nearly all of our medical offices, KPNW promotes pharmacy as an integral part of the healthcare team. KPNW pharmacists are valued and influential at every level of our organization.

KPNW is advancing the scope of pharmacy practice by developing opportunities for population management and direct patient care services in a variety of clinical specialties. With more than 50 collaborative drug therapy management protocols and authorized pharmacist prescribing, pharmacists have ample opportunity to provide direct patient care across a variety of settings.

Examples of CDTMs the PGY1 Resident is involved with:
• Diabetes
• Dyslipidemia
• Hypertension
• International Travel Clinic
• Anticoagulation
• Oncology

Pharmacist Prescribing in OR and WA:
• Naloxone
• Oral Contraceptives

Awards and Accomplishments

• Pharmacy Quality Alliance (PQA) Excellence in Quality Award, 2022
• National Committee for Quality Assurance (NCQA) rating of 4.5, 2023
• J.D. Power – Highest Member Satisfaction
• The Leapfrog Group – A Grade for patient safety, 2022 (both Westside and Sunnyside Medical Centers received an A grade for patient safety from the Leapfrog Group, an independent industry watchdog [A complete list of Leapfrog Hospital Safety Score results can be found at hospitalsafetyscore.org])
• Business Group on Health Best Employers Awards for Excellence in Health & Wellbeing, Excellence in Mental Health and Excellence in Health Equity, 2022
• America’s 50 Best Hospitals, healthgrades, 2022
• J.D. Power Highest Ranking for Customer Satisfaction with Commercial Member Health Plans
• Infectious Diseases Society of America (IDSA) Antimicrobial Stewardship Center of Excellence (both Sunnyside and Westside Medical)
• Excellence in Stroke Care Awards, American Heart Association & American Stroke Association, 2023 (both Sunnyside and Westside Medical Centers)
• Kaiser Permanente Sunnyside Medical Center was named one of America’s Best Maternity Hospitals by Newsweek, 2023
• Insure.com rated Kaiser Permanente the nation’s Best Health Insurance Company of 2023 for customer satisfaction
• Kaiser Permanente is again (fifth year in a row) one of the World’s Most Ethical Companies, according to Ethisphere, an independent group that monitors business ethics

Portland At A Glance

---

Learning Experiences

Many of our past residents continue to serve KPNW as student and resident preceptors, which is part of the reason we place our residents’ growth and proficiency as top priorities in each learning experience we offer. We strive to create an enriching experience by offering a flexible schedule designed to drive each resident to reach their full potential.

Core Experience

• Orientation [Airport Way Center (AWC) Pharmacy Administration Building, NE Portland]
• Ambulatory Care I & II [Portland metro area]
• Medication Therapy Management [AWC, NE Portland]
• Drug Use Management [AWC, NE Portland]
• Outpatient Pharmacy [Westside Medical Office, Hillsboro]
• Anticoagulation [AWC, NE Portland]
• Inpatient: Glycemic Control [Sunnyside Medical Center, Clackamas]
• Inpatient: Infectious Disease [Sunnyside Medical Center, Clackamas]
• Transitions of Care [AWC, NE Portland]

Elective Experience

• Academia / Teaching Certificate
• Pharmacy Administration
• Clinical Informatics
• Ambulatory Mental Health (subject to preceptor availability)
• Inpatient: Intensive Care Unit
• Ambulatory Chronic Non-Malignant Pain Management
• Ambulatory Oncology/Hematology
• International Travel Clinic [AWC, NE Portland]

Longitudinal Experience

• Outpatient Anticoagulation Service Staffing – every other Saturday, starting in October [option for remote work]
• Pharmacy Practice and Administration
• Residency Project

---

Requirements for Acceptance

• Graduate of an Accreditation Council for Pharmacy Education (ACPE)-accredited (or ACPE candidate status) school of pharmacy.
• Must be licensed as an Intern Pharmacist in the state of Oregon by the first day of the residency.
• Must be licensed as a Pharmacist in the state of Oregon within 120 days and Washington by December 31st (sooner is highly encouraged).
• Candidates must be registered in the National Matching Services, Inc. (NMS).
• Candidates must participate in the ASHP Matching Program.
• Program NMS Code: 152313 and ASHP Program Code: 94003

---

Application Requirements

• Application process through PhORCAS
• Statement of Interest/Letter of Intent
• Curriculum Vitae
• Official Pharmacy School transcripts sent to PhORCAS
• Three letters of references/recommendations utilizing the form in PhORCAS
• Application Deadline: January 2, 2024

---

Interview Details

• Selected applicants will be offered telephone interviews (with current residents and then with RPD) occurring in January (required for application advancement).
• Successful phone interviewees will be offered a final interview occurring in mid-February (required for application advancement).
• Click here to link to the Virtual Information Sessions 
  • November 15th – 12p.m. – 1p.m. PST
  • December 12th – 1p.m. – 2p.m. PST

**This residency agrees that no person at this residency will solicit, accept, or use any ranking-related information from any residency applicant**

Back to all programs